Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer Drugs Approved Based on Biomarkers and Not Tumor Type-FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers.

× No keyword cloud information.

44 in total

Review 1. Cancer drug development: The missing links.

Authors: Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal: Exp Biol Med (Maywood) Date: 2019-04-08

Review 2. PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Authors: Mustafa Khasraw; David A Reardon; Michael Weller; John H Sampson
Journal: Clin Cancer Res Date: 2020-06-11 Impact factor: 12.531

3. Low clinical adoption of tumor genomic profiling: cause for concern?

Authors: Michael W Drazer; Randy F Sweis
Journal: J Med Econ Date: 2018-05-15 Impact factor: 2.448

4. Missing Conflict of Interest Disclosure.

Authors:
Journal: JAMA Oncol Date: 2018-10-01 Impact factor: 31.777

Review 5. Mismatch repair-based stratification for immune checkpoint blockade therapy.

Authors: Lihong Zhang; Yang Peng; Guang Peng
Journal: Am J Cancer Res Date: 2018-10-01 Impact factor: 6.166

6. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.

Authors: Tomomi W Nobashi; Yuko Nishimoto; Yujiro Kawata; Hidetaka Yutani; Masaki Nakamura; Yuichi Tsuji; Atsushi Yoshida; Akihiko Sugimoto; Takayuki Yamamoto; Israt S Alam; Satoshi Noma
Journal: Br J Radiol Date: 2020-08-12 Impact factor: 3.039

Review 7. Biomarkers of immunotherapy response in breast cancer beyond PD-L1.

Authors: Nuria Chic; Fara Brasó-Maristany; Aleix Prat
Journal: Breast Cancer Res Treat Date: 2021-10-21 Impact factor: 4.872

Review 8. Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.

Authors: Raffaella Casolino; Vincenzo Corbo; Philip Beer; Chang-Il Hwang; Salvatore Paiella; Valentina Silvestri; Laura Ottini; Andrew V Biankin
Journal: Cancers (Basel) Date: 2022-06-30 Impact factor: 6.575

9. Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures.

Authors: Annabel Meireson; Simon J Tavernier; Sofie Van Gassen; Nora Sundahl; Annelies Demeyer; Mathieu Spaas; Vibeke Kruse; Liesbeth Ferdinande; Jo Van Dorpe; Benjamin Hennart; Delphine Allorge; Filomeen Haerynck; Karel Decaestecker; Sylvie Rottey; Yvan Saeys; Piet Ost; Lieve Brochez
Journal: Cancers (Basel) Date: 2021-05-27 Impact factor: 6.639

Review 10. Biomarkers of therapeutic response with immune checkpoint inhibitors.

Authors: Poorva Bindal; Jhanelle E Gray; Theresa A Boyle; Vaia Florou; Sonam Puri
Journal: Ann Transl Med Date: 2021-06